SwanBio Therapeutics

About:

SwanBio Therapeutics is a gene therapy company focused on the development and commercialisation of genetically defined therapies.

Website: http://www.swanbiotx.com/

Top Investors: Mass General Brigham Ventures, Partners Innovation Fund, Syncona Partners LLP

Description:

SwanBio Therapeutics is a developer of a therapeutic technology designed to deliver dramatic clinical efficacy for the treatment of neurological diseases. The company's technology focuses on the development and commercialisation of genetically defined therapies for the treatment of neurological disorders.

Total Funding Amount:

$118M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Bala Cynwyd, Pennsylvania, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)swanbiotx.com

Founders:

Florian Eichler, Karen Kozarsky, Rachel Salzman

Number of Employees:

11-50

Last Funding Date:

2023-10-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai